(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
latest_posts
- 1
Experts who once backed 'shaken baby' science now fight to free imprisoned caregivers - 2‘Harry Potter and the Philosopher’s Stone’ trailer is raising eyebrows among Potterheads: ‘Where’s the whimsical color?’
- 3'Heated Rivalry's Ilya Rozanov is now a queer icon in Russia
- 4Vote in favor of your #1 sort of juice
- 5A Lone Wolf Outsmarted Hunters in the Black Forest and Then Vanished
- How do my eyes adjust to the dark and how long does it take?
- Your guide to how to safely thaw and cook your Thanksgiving turkey this year, according to experts
- 'I was diagnosed with incurable brain cancer on holiday'
- Mom finds out she has cancer after noticing something was off while breastfeeding
- Why do people get headaches and migraines? A child neurologist explains the science of head pain and how to treat it
- Finding China: Four Urban areas for a Remarkable Excursion
- Los Angeles County sees significant uptick in norovirus cases, officials say
- Idris Elba is the king of the stress-watch
- Are Saturn's rings made of a lost, shattered moon? New evidence arises for the case
